Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Streptococcus mutans cytoplasmic membrane is a vital phospholipid bilayer that serves as the primary barrier between the bacterium's internal environment and the external oral cavity (Loesche, 1986). It plays a crucial role in maintaining cellular homeostasis, regulating the transport of nutrients and ions, and facilitating energy production through the maintenance of a proton motive force (Matsui & Cvitkovitch, 2010). As a key component of S. mutans, which is the primary etiologic agent of dental caries, the membrane is a significant target for various antimicrobial agents (Quivey et al., 2000). Drugs targeting this structure, such as chlorhexidine or nisin, typically act by disrupting its integrity or forming pores, leading to the leakage of essential cytoplasmic components like potassium and ATP (Jenkins et al., 1988; Brogden, 2005). This disruption ultimately results in bacterial cell death, making the membrane a focal point for developing anti-caries therapies and oral hygiene products. Furthermore, the membrane's composition, including its fatty acid profile, can be altered by the bacterium to adapt to environmental stresses like low pH, which is critical for its survival in dental plaque (Quivey et al., 2000). Understanding these adaptive mechanisms and the structural vulnerabilities of the membrane is essential for the design of next-generation oral therapeutics.
Disruption of membrane integrity, pore formation, and dissipation of the proton motive force leading to leakage of intracellular contents and cell death (Jenkins et al., 1988; Brogden, 2005).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus mutans cytoplasmic membrane.